TUSTIN, Calif.--(BUSINESS WIRE)--Toshiba America Medical Systems, Inc. today announced faCTor64, the Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using CT Angiography, Following CorE 64: A Randomized Control Study. Toshiba’s CorE 64 (Coronary Evaluation on 64) study is taking place across seven countries comparing the use of CT as the primary diagnostic tool for detecting cardiovascular diseases and disorders, as compared to cardiac catheterization.
